On November 6, 2025, Xiangyang PRCXI held a grand opening ceremony at the Dawan District Industrial Park in Dongjin Town, Xiangyang City. Centered on the theme "Gathering Momentum, Pioneering Innovation, Building the Future Together," the ceremony was attended by government representatives including Wang Pingwu, Deputy Secretary of the Party Working Committee and Director of the Administrative Committee of Xiangyang Dongjin New District (Economic Development Zone), and Qiu Jun, Member of the Party Working Committee and Deputy Director of the Administrative Committee of Xiangyang Dongjin New District (Economic Development Zone). Joining them were management members such as Zhu Bin, Chairman of PRCXI Bio, along with partners from various sectors and representatives from partner universities. All gathered to witness PRCXI Bio's significant strategic expansion in the medical injection molding sector.
Deepening Industrial Synergy Building Regional Innovation and Development Together
The ceremony commenced promptly at 2:45 PM. In a solemn yet vibrant atmosphere, Executive General Manager Li Zhuxun of Xiangyang PRCXI Biomedical Technology Co., Ltd. presided over the opening proceedings. He first extended a warm welcome to all leaders and distinguished guests in attendance, then introduced the founding background and development plans of Xiangyang PRCXI, officially kicking off the ceremony.
In a solemn yet enthusiastic atmosphere, Zhu Bin, Chairman of PRCXI Bio, stated in his address: "The completion of the Xiangyang manufacturing base marks a significant step forward in the strategic layout of PRCXI's manufacturing system. Leveraging Xiangyang's industrial strengths and policy support, we will focus on developing medical-grade injection-molded products to further refine our manufacturing capabilities and enhance our core competitiveness in the field of life science automation."
Subsequently, Professor Li Xu, representing university users, delivered remarks as a special guest speaker. From the perspective of industry-academia-research collaboration, he noted: "PRCXI Bio's establishment in Xiangyang will provide crucial technical support for regional life science research. We look forward to deeper cooperation in talent development, technological R&D, and other areas in the future."
Finally, Wang Pingwu, Deputy Secretary of the Party Working Committee and Director of the Administrative Committee of Xiangyang Dongjin New District, delivered a speech: "As a leading enterprise in the field of life science automation, the establishment of PRCXI Bio will inject new momentum into the development of Xiangyang's biomedical industry. We will fully support the company's growth in PRCXI and look forward to deepening cooperation between both parties in areas such as technological innovation and industrial upgrading."
Enhance the manufacturing system to solidify the foundation for future development.
In the presence of all attendees, a solemn ribbon-cutting and plaque-unveiling ceremony was held on-site, marking the official launch of PRCXI Bio's strategic expansion into the medical injection molding sector.
Subsequently, the guests toured Xiangyang PRCXI's production workshops and exhibition center, expressing high praise for the company's innovations in manufacturing processes and its quality control system.
During the subsequent symposium, both parties engaged in in-depth discussions on topics including talent cultivation, technological R&D, and industrial chain collaboration. The completion of the Xiangyang manufacturing base signifies the further refinement of PRCXI Bio's full-chain strategy of "in-house R&D, in-house production, in-house inspection, and in-house testing." The company has now established a comprehensive manufacturing system covering four core processes: turning and milling, sheet metal fabrication, mold making, and injection molding.
The successful commencement of operations at Xiangyang Company marks not only a significant milestone in PRCXI Bio's national expansion strategy, but also a crucial step in advancing "Made in China 2025" and strengthening core competitiveness in life sciences. This achievement signifies a solid stride forward in the company's journey toward establishing an independent and controllable manufacturing system.
About PRCXI Medical
Xiangyang PRCXI Biomedical Technology Co., Ltd., a wholly-owned subsidiary of PRCXI Bio focused on the medical injection molding sector, is dedicated to providing high-quality, high-reliability consumables and components for life science automation.
We build upon medical-grade quality standards, exclusively utilizing USP Class VI-grade resin materials. Our production environment strictly adheres to Class 100,000 cleanroom standards, ensuring complete cleanliness and control throughout the entire process from raw materials to finished products.
Leveraging PRCXI Bio's technical expertise and manufacturing experience in automated equipment, we are dedicated to developing a "triple-free" product system-free of DNase, RNase, and pyrogens. This comprehensive portfolio spans pipette tips, testing consumables, and customized components, delivering safe and reliable consumables for cutting-edge fields such as precision medicine, molecular diagnostics, and cell therapy.